Bukwang Pharmaceutical Co., Ltd. (003000.KS) KSC

3,680.00

+70(+1.94%)

Updated at October 20 10:23AM

Currency In KRW

Valuation

Market Cap314.21B
Enterprise Value303.54B
P/E Ratio30.13
PEG Ratio0.03
Price/Sales Ratio2.03
Price/Book Ratio1.01
Enterprise/Revenue2.05
Enterprise/EBITDA11.73

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.05
Operating Margin0.06

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue160.09B
Revenue/Share2,617.23
Gross Profit74.34B
EBITDA6.98B
Net Income-2.64B
Diluted EPS-38.59

Balance Sheet

Total Cash139.59B
Total Cash/Share2,039.09
Total Debt80.24B
Total Debt/Equity0.32
Current Ratio5.77
Book Value Per Share3,659.55

Price History

52-Week Change-28.54
52-Week High5,700
52-Week Low3,200
Moving Average 50 Days3,509
Moving Average 200 Days3,998.08

Statistics

Average Volume557,494
Shares Outstanding98.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor11:10
Last Split DateDecember 29, 2020